IL6 and prostate carcinoma: While this finding is concordant with research on IL-6 and CRP in lung cancer patients undergoing chemotherapy [59] and in prostate cancer patients treated with androgen deprivation therapy [28], it is in contrast to research examining cytokines and fatigue in other cancer patient populations [30,58].